News

Stephen Byard shares his thoughts with Pharmaceutical Technology on the strategies we use for streamlining small molecule formulation development when bridging from candidate selection to first-in-human clinical testing.

Pharma will looks for ways to streamline development in 2023, the thoughts of Dr. Sarah Stevens shared in a recent article published on Pharma Manufacturing online.

Quotient Sciences is a multi-category award winner of the 2023 CDMO Leadership Awards. Now in its 12th year, the CDMO Leadership Awards recognizes superior performance by contract development and manufacturing organizations (CDMO's) across multiple categories, as voted by customers.

An increasing number of drug development pipelines are turning towards the use of HPAPIs to target rare and 'undruggable' diseases. Speaking with CPHI Online, Quotient Sciences share their thoughts on the HPAPI supply chain, manufacturing and handling considerations.

An expansion of our early-phase formulation development capabilities for oral dosage forms at our Nottingham, UK, facility builds upon our existing formulation capabilities.

Stuart McDougall, Quotient Sciences' Principal Research Fellow of Bioanalytical Services, contributes to the European Bioanalysis Forum Workshop on the Harmonized Implementation of the ICH M10 Guideline.